Australia markets closed

Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
22.12+0.25 (+1.14%)
At close: 04:00PM EDT
21.75 -0.37 (-1.67%)
After hours: 07:22PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Cash flows from operating activities
Net income
-296,814
-205,275
-176,063
-140,848
-84,553
Depreciation & amortisation
14,067
12,493
10,421
8,267
5,942
Stock-based compensation
78,434
78,130
120,893
76,673
43,383
Change in working capital
-3,097
-51,547
-98,293
228,662
-61,078
Accounts receivable
39,567
1,410
8,845
-9,409
-184
Accounts payable
22,607
32,998
-6,589
2,628
-821
Other working capital
-402,696
-330,627
-188,908
147,745
-107,753
Other non-cash items
20,844
18,326
2,910
266
525
Net cash provided by operating activities
-196,214
-153,890
-136,131
171,312
-95,801
Cash flows from investing activities
Investments in property, plant and equipment
-206,482
-176,737
-52,777
-23,567
-11,952
Purchases of investments
-20,995
-246,141
-223,391
-240,703
-278,964
Sales/maturities of investments
390,802
326,723
270,751
122,592
50,138
Net cash used for investing activities
49,378
-96,155
-5,417
-141,678
-240,778
Cash flows from financing activities
Debt repayment
-0.001
-
-
0
0
Common stock issued
-
-
0
0
250,479
Other financing activities
-
250,000
60,000
-
-
Net cash used provided by (used for) financing activities
2,744
253,053
65,186
11,305
257,948
Net change in cash
-144,092
3,008
-76,362
40,939
-78,631
Cash at beginning of period
202,249
108,005
184,434
143,583
221,804
Cash at end of period
58,157
110,891
108,005
184,434
143,583
Free cash flow
Operating cash flow
-196,214
-153,890
-136,131
171,312
-95,801
Capital expenditure
-206,482
-176,737
-52,777
-23,567
-11,952
Free cash flow
-402,696
-330,627
-188,908
147,745
-107,753